Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kronos Bio Inc.

    NASDAQ: KRON · Real-Time Price · USD
    0.89
    -0.00 (-0.29%)
    At close: Jun 16, 2025, 3:56 PM
    0.89
    -0.45%
    After-hours: Jun 16, 2025, 04:01 PM EDT

    Kronos Bio Statistics

    Share Statistics

    Kronos Bio has 60.97M shares outstanding. The number of shares has increased by 1.46% in one year.

    Shares Outstanding

    n/a
    		 60.97M

    Shares Change (YoY)

    n/a
    		 1.46%

    Shares Change (QoQ)

    n/a
    		 1.04%

    Owned by Institutions (%)

    n/a
    		 32.58%

    Shares Floating

    n/a
    		 39.42M

    Failed to Deliver (FTD) Shares

    n/a
    		 146,744

    FTD / Avg. Volume

    n/a
    		 18.85%

    Short Selling Information

    The latest short interest is 754.26K, so 1.24% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 754.26K

    Short % of Shares Out

    n/a
    		 1.24%

    Short % of Float

    n/a
    		 1.66%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.66 and the forward PE ratio is -0.66. Kronos Bio's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.66

    Forward PE

    n/a
    		 -0.66

    PS Ratio

    n/a
    		 5.79

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 0.65

    P/FCF Ratio

    n/a
    		 -0.87

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kronos Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.54, with a Debt / Equity ratio of 0.28.

    Current Ratio

    n/a
    		 7.54

    Quick Ratio

    n/a
    		 7.54

    Debt / Equity

    n/a
    		 0.28

    Debt / EBITDA

    n/a
    		 -0.4

    Debt / FCF

    n/a
    		 -0.38

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,231,000

    Profits Per Employee

    n/a
    		 $-10,759,875

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0.08

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -14.42% in the last 52 weeks. The beta is 1.64, so Kronos Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.64

    52-Week Price Change

    n/a
    		 -14.42%

    50-Day Moving Average

    n/a
    		 0.78

    200-Day Moving Average

    n/a
    		 0.91

    Relative Strength Index (RSI)

    n/a
    		 69.46

    Average Volume (20 Days)

    n/a
    		 778,609

    Income Statement

    In the last 12 months, Kronos Bio had revenue of 9.85M and earned -86.08M in profits. Earnings per share was -1.43.

    Revenue

    n/a
    		 9.85M

    Gross Profit

    n/a
    		 9.85M

    Operating Income

    n/a
    		 -92.89M

    Net Income

    n/a
    		 -86.08M

    EBITDA

    n/a
    		 -61.72M

    EBIT

    n/a
    		 -63.43M

    Earnings Per Share (EPS)

    n/a
    		 -1.43
    Full Income Statement

    Balance Sheet

    The company has 84.57M in cash and 24.9M in debt, giving a net cash position of 59.67M.

    Cash & Cash Equivalents

    n/a
    		 84.57M

    Total Debt

    n/a
    		 24.9M

    Net Cash

    n/a
    		 59.67M

    Retained Earnings

    n/a
    		 -594.94M

    Total Assets

    n/a
    		 108.14M

    Working Capital

    n/a
    		 93.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -65.44M and capital expenditures -4K, giving a free cash flow of -65.44M.

    Operating Cash Flow

    n/a
    		 -65.44M

    Capital Expenditures

    n/a
    		 -4K

    Free Cash Flow

    n/a
    		 -65.44M

    FCF Per Share

    n/a
    		 -1.09
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -943.21% and -874.08%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -943.21%

    Pretax Margin

    n/a
    		 -874.08%

    Profit Margin

    n/a
    		 -874.08%

    EBITDA Margin

    n/a
    		 -626.69%

    EBIT Margin

    n/a
    		 -943.21%

    FCF Margin

    n/a
    		 -664.49%

    Dividends & Yields

    KRON does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KRON is $1.62, which is 82% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $1.62

    Price Target Difference

    n/a
    		 82%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -7.11

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist